BR112014000248A2 - fago geneticamente modificado e uso deste - Google Patents
fago geneticamente modificado e uso desteInfo
- Publication number
- BR112014000248A2 BR112014000248A2 BR112014000248A BR112014000248A BR112014000248A2 BR 112014000248 A2 BR112014000248 A2 BR 112014000248A2 BR 112014000248 A BR112014000248 A BR 112014000248A BR 112014000248 A BR112014000248 A BR 112014000248A BR 112014000248 A2 BR112014000248 A2 BR 112014000248A2
- Authority
- BR
- Brazil
- Prior art keywords
- genetically modified
- modified phage
- phage
- genetically
- modified
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/00088—Details for redistribution
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2795/00—Bacteriophages
- C12N2795/00011—Details
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2795/00—Bacteriophages
- C12N2795/00011—Details
- C12N2795/10011—Details dsDNA Bacteriophages
- C12N2795/10311—Siphoviridae
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Virology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Plant Pathology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP11173033A EP2543720A1 (en) | 2011-07-07 | 2011-07-07 | Genetically modified phage and use thereof |
| US13/178,402 | 2011-07-07 | ||
| US13/178,402 US9920323B2 (en) | 2011-07-07 | 2011-07-07 | Genetically modified phage and use thereof |
| EP11173033.9 | 2011-07-07 | ||
| PCT/EP2012/063244 WO2013004817A1 (en) | 2011-07-07 | 2012-07-06 | Genetically modified phage and use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BR112014000248A2 true BR112014000248A2 (pt) | 2017-07-11 |
| BR112014000248B1 BR112014000248B1 (pt) | 2021-01-19 |
Family
ID=46458540
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112014000248-7A BR112014000248B1 (pt) | 2011-07-07 | 2012-07-06 | célula hospedeira bacteriana compreendendo um fago geneticamente modificado, kit, processo para preparar a célula hospedeira bacteriana e processo para produzir uma biomolécula de interesse |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP2729563B1 (pt) |
| JP (2) | JP6174019B2 (pt) |
| CN (1) | CN103797113B (pt) |
| AR (1) | AR087330A1 (pt) |
| BR (1) | BR112014000248B1 (pt) |
| CA (1) | CA2841805C (pt) |
| CL (1) | CL2014000033A1 (pt) |
| ES (1) | ES2699652T3 (pt) |
| IN (1) | IN2014MN00024A (pt) |
| WO (1) | WO2013004817A1 (pt) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2956107A1 (en) | 2014-07-25 | 2016-01-28 | Delphi Genetics | Improved host cell for producing proteins |
| JP6779513B2 (ja) * | 2016-07-11 | 2020-11-04 | 大学共同利用機関法人情報・システム研究機構 | インビボクローニング可能な細胞株をスクリーニングするための方法、インビボクローニング可能な細胞株の製造方法、細胞株、インビボクローニング方法、及びインビボクローニングを行うためのキット |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4952496A (en) | 1984-03-30 | 1990-08-28 | Associated Universities, Inc. | Cloning and expression of the gene for bacteriophage T7 RNA polymerase |
| US7153652B2 (en) * | 1995-10-02 | 2006-12-26 | The Board Of Trustees Of The Leland Stanford Junior University | Mismatch repair detection |
| US6355412B1 (en) | 1999-07-09 | 2002-03-12 | The European Molecular Biology Laboratory | Methods and compositions for directed cloning and subcloning using homologous recombination |
| AU2001284914B2 (en) * | 2000-08-15 | 2006-02-09 | New Technologies Holdings Pte Ltd | Phage-dependent superproduction of biologically active protein and peptides |
| CA2435956C (en) | 2001-02-23 | 2012-07-10 | Universite Libre De Bruxelles | Method for the selection of recombinant clones comprising a sequence encoding an antidote protein to toxic molecule |
| BR0214542A (pt) | 2001-12-12 | 2005-08-16 | Lilly Co Eli | Célula hospedeira, sistema de expressão, e, processos de preparação de uma célula hospedeira, e de uma proteìna alvo |
| EP1859043A4 (en) * | 2005-02-22 | 2009-06-03 | David Tabaczynski | PHAGEN DERIVED VECTORS AND PROCEDURE FOR PROTEIN EXPRESSION |
| GB0709061D0 (en) | 2007-05-11 | 2007-06-20 | Avecia Biolog Ltd | Expression system |
-
2012
- 2012-07-06 AR ARP120102472A patent/AR087330A1/es active IP Right Grant
- 2012-07-06 BR BR112014000248-7A patent/BR112014000248B1/pt active IP Right Grant
- 2012-07-06 EP EP12732669.2A patent/EP2729563B1/en active Active
- 2012-07-06 JP JP2014517821A patent/JP6174019B2/ja active Active
- 2012-07-06 WO PCT/EP2012/063244 patent/WO2013004817A1/en active Application Filing
- 2012-07-06 ES ES12732669T patent/ES2699652T3/es active Active
- 2012-07-06 CN CN201280042917.7A patent/CN103797113B/zh active Active
- 2012-07-06 CA CA2841805A patent/CA2841805C/en active Active
-
2014
- 2014-01-06 IN IN24MUN2014 patent/IN2014MN00024A/en unknown
- 2014-01-07 CL CL2014000033A patent/CL2014000033A1/es unknown
-
2017
- 2017-03-08 JP JP2017044126A patent/JP2017158551A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CN103797113B (zh) | 2018-08-10 |
| BR112014000248B1 (pt) | 2021-01-19 |
| CA2841805A1 (en) | 2013-01-10 |
| IN2014MN00024A (pt) | 2015-06-12 |
| EP2729563A1 (en) | 2014-05-14 |
| JP2014520519A (ja) | 2014-08-25 |
| CL2014000033A1 (es) | 2014-12-12 |
| CN103797113A (zh) | 2014-05-14 |
| AR087330A1 (es) | 2014-03-19 |
| JP6174019B2 (ja) | 2017-08-02 |
| CA2841805C (en) | 2020-12-15 |
| JP2017158551A (ja) | 2017-09-14 |
| EP2729563B1 (en) | 2018-09-12 |
| ES2699652T3 (es) | 2019-02-12 |
| WO2013004817A1 (en) | 2013-01-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO6870033A2 (es) | Compuestos terapéuticos y métodos de uso relacionados | |
| CO6930362A2 (es) | Compuesto heterocíclico y su uso | |
| CO7020870A2 (es) | Anticuerpos anti-htra1 y métodos de uso | |
| DK2683731T3 (da) | C4-monomethyl-triterpenoidderivater og fremgangsmåder til anvendelse deraf | |
| BR112014012137A2 (pt) | anticorpos anti-fgfr2 e suas utilizações | |
| CL2014002086A1 (es) | Anticuerpos cd47 y métodos de uso los mismos | |
| CO6821892A2 (es) | Anticuerpos anti-angptl3 y usos de los mismos | |
| BR112013012953A2 (pt) | benzoxazepinas asn inhibidoras de p13k/m tor e métodos de seu uso e fabricação | |
| BR112014028366A2 (pt) | anticorpos anti-ly6e e imunoconjugados e métodos de uso | |
| BR112012017441A2 (pt) | compostos e métodos | |
| DK2806892T3 (da) | Kombineret terapeutisk anvendelse af antistoffer og endoglycosidaser | |
| BR112014002716A2 (pt) | anticorpos anti-poliubiquitina e métodos de uso | |
| CO7000747A2 (es) | Anticuerpos anti-lrp5 y métodos de uso | |
| BR112013014119A2 (pt) | novos moduladores e métodos de uso | |
| BR112013032426A2 (pt) | composições probióticas e métodos | |
| CO7000773A2 (es) | Composiciones intranasales de dexmedetomidina y métodos de uso de ellas | |
| BR112014006291A2 (pt) | composição e utilização da composição | |
| FI20105572A0 (fi) | Muokattu beeta-laktamaasi ja siihen liittyvät menetelmät ja käytöt | |
| BR112014012590A2 (pt) | anticorpos anti-cd98 e métodos de uso dos mesmos | |
| CO7020907A2 (es) | Inhibidores de quinurenina-3-monooxigenasa, composiciones farmacéuticas y métodos de uso de los mismos | |
| BR112013014644A2 (pt) | composição farmacêutica e complexo | |
| CO6940375A2 (es) | Ensayo de lisiloxidasa-homólogo 2 y métodos de uso del mismo | |
| CO6781486A2 (es) | Compuestos y su uso | |
| BR112012029412A2 (pt) | partículas funcionalizadas e uso destas | |
| CR20130133A (es) | Composiciones de anticuerpo y mètodos de uso |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B06T | Formal requirements before examination [chapter 6.20 patent gazette] | ||
| B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 06/07/2012, OBSERVADAS AS CONDICOES LEGAIS. |
|
| B25A | Requested transfer of rights approved |
Owner name: R.P. SCHERER TECHNOLOGIES, LLC (US) |
|
| B25L | Entry of change of name and/or headquarter and transfer of application, patent and certificate of addition of invention: publication cancelled |
Owner name: DELPHI GENETICS (BE) Free format text: ANULADA A PUBLICACAO CODIGO 25.1 NA RPI NO 2652 DE 03/11/2021 POR TER SIDO INDEVIDA. |
|
| B25A | Requested transfer of rights approved |
Owner name: R.P. SCHERER TECHNOLOGIES, LLC (US) |